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SUMMARY 
This study investigated patterns of medicine use among Spanish drivers. The study was conducted in the 
fall of 1993 on 1500 drivers aged over 16, all of whom completed accordingly and then returned the 
questionnaires. Among those surveyed, 45.1% had used drugs at  least once in the previous year, while 
17.3% of drivers surveyed were using medicines chronically. Chronic users, the majority of whom were 
female and belonging to the older age group, were using an average of two drugs. Central nervous 
system drugs (21.7%), respiratory system drugs (19.2%), cardiovascular system drugs (14.9%) and 
alimentary tract drugs (14.3%) were the most frequent groups of medication used, Of those surveyed 
76.5% who took drugs regularly had never been warned by health professionals about the effects of the 
medication use on driving skills. The study shows both how often drivers use medication as well as the 
need to inform patients and drivers about the effect of medication on driving performance. 
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INTRODUCTION 
Road traffic accidents have become an important 
health problem in developed countries and their 
prevention has long been a priority issue. 
Undoubtedly, alcohol consumption is one of the 
main causes of road traffic accidents. Nevertheless, 
it is often forgotten that other substances, such as 
certain forms of medication and illegal drugs, 
impair psychomotor skills related to driving.] 
The relation between drugs, driving and road 
traffic accidents is a complex one. In laboratory 
experiments therapeutic doses of several drugs 
have been shown to impair psychomotor skills 
related to driving.2 However, there are certain 
aspects which need clarifying. One is the relation 
between drug concentration and driving impair- 
ment; another, the legal consideration of drug 
levels similar to those of alcohol, e t ~ . ~  In addition, 
information relating to the frequency of drug-use 
by drivers and the percentage of people who drive 
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while under the influence of psychopharmaco- 
logical agents is scarce, and the figures available 
differ significantly. Perhaps this may be attributed 
to the diversity of exploratory methods used in the 
course of the studies undertaken; these include 
mailed questionnaires, prescription records, per- 
sonal or telephone interviews, e t ~ . ~ - ~  What is 
more, drugs have very often been found in body 
fluids among drivers involved in road traffic 
accidents . 4-8 
It has recently been estimated that at least 10% 
of all people killed or injured in road accidents 
were using some kind of psychotropic medication 
that could have been considered a contributory 
factor. This represents a direct cost each year to the 
European Community of at least 7 billion ECUs, 
5000 deaths and 150,000 injuries.l0 
Under European Community Council Directive 
91/439/EEC, authorities responsible for the issuing 
of driving licences must determine the applicant's 
lack of impairment due to their use of alcohol, 
illegal drugs and medicines," although there exist 
difficulties concerning the implementation o f  this 
Directive. lo 
In most countries information about medication 
use and road safety is scarce and incomplete, and 
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the present national study was carried out on a 
sample of Spanish drivers with a view to analysing 
the patterns of medication used by this section of 
the population, and how the use of medication 
could impair driving ability. Consideration has 
also been given to the information received by 
health professionals concerning the effect of 
medication on driving performance, thereby facil- 
itating the proposal of measures as regards road 
safety. The study also analyses health status, illegal 
drugsI2 and alcohol cons~mption,’~ the results of 
which have been published elsewhere. 
and returned. All the questionnaires were checked 
for completeness and accuracy. Of these, 1500 were 
properly completed. Further questionnaires 
received (220 by mid- 1994) were not considered 
for analysis. Of the mailed questionnaires, 2405 
were sent back by mid-1994 because a wrong 
address was given. 
The analysis of the data was carried out in the 
Data Processing Center at Valladolid University, 
using the statistical package SAS 6.07 version 
(under the VAX/VMS 5 version). 
RESULTS 
METHODS 
The questionnaire used included, among other 
items, sociodemographic data and patterns of 
medicine use and driving. Drivers were asked 
about the medicines they had used in the previous 
year and were using at present (when the survey 
was carried out). All the information pertaining to 
the medication (up to seven different drugs) was 
recorded: in each case they were asked about the 
registered name of the medicine they were using, 
the reasons for using it, the intake duration, and 
whether the medicine used was over-the-counter or 
medically prescribed. Each registered pharma- 
ceutical preparation was coded following the 
Anatomical Therapeutic Chemical classification 
system.I4 Chronic drug use was assessed among 
those surveyed who, at the time of the study, were 
using medication. Chronic or regular use was 
defined as when the person concerned had been 
using the drug on a daily basis for at least 1 month. 
The Summary of Product Characteri~tics’~ for each 
medication was reviewed, and it was stated 
whether or not there was a warning about the 
effect of the medication on the ability to drive or 
use machinery. Those who drank at least once a 
weekI3 were termed current alcohol drinkers. 
The target population were those members 
holding a driving licence. A sample of 12,000 
drivers was randomly selected (by age group and 
sex) from the National Official Register of Spanish 
Drivers. The sample size selection was based on 
response figure rates obtained from this register, 
and the aim was to obtain a final sample of at least 
1500 individuals. 
The questionnaire, with instructions for comple- 
tion, were mailed to selected drivers between 26 
September and 15 October 1993. By 15 December 
of that year, 1598 questionnaires were completed 
The response rate (1720 out of 12,000: 14.3%) was 
as expected, and similar to that obtained earlier 
from this register (1116 out of 8200: 13.6%). 
However, we must recognize that this is a very 
low rate when compared with those obtained in 
other developed countries. The reasons for this 
could be: (i) the complexity of the questionnaire, 
dealing with information on matters as diverse as 
health status, use of medication, alcohol and illegal 
drugs. Therefore, completion of the questionnaire 
could be difficult for some people with a low edu- 
cation level. (ii) As it was clearly indicated in the 
questionnaire that the study was being carried out 
by the National Traffic Agency, many drivers could 
have been discouraged from answering the ques- 
tionnaire. (iii) Possibly, yet most probably, the fact 
that in the official register of Spanish drivers a great 
number of addresses are incorrect, although every 
drivers should, according to law, give notification 
of any change in address. The said register is used 
for notification of sanctions and fines; a wrong 
address in the register prevents the driver from 
being notified, and prescription ensues if, after a 
certain length of time, the driver is not 
This study is based on 1500 drivers who, as has 
already been stated, completed the question- 
naire.I2-l3 The sample distribution of respondents 
(by age group and sex) did not differ ( p  > 0.05) 
from that of all Spanish drivers. Table 1 shows the 
gender distribution of the sample as regards their 
sociodemographic characteristics. The sample 
could not be compared with the entire driving 
population on additional variables because the 
official register of Spanish drivers has information 
regarding only age, sex, type of driving licence and 
address. 
Of the Spanish drivers surveyed, 45.1 YO (676 out 
of 1500, Table 2) had used drugs at least once in the 
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Table 1 -Sociodemographic characteristics of the 
driving population surveyed 
Male Female 
n YO n YO 
Total 1016 67.7 484 32.3 
Age range 
16-20 
21-30 
31-40 
41-50 
5 1-60 
61-70 
> 70 
Marital status 
Single 
Married 
Divorcee 
Widowed 
Educational level 
No schooling 
Primary 
Middle 
Secondary 
High 
University 
88 
27 1 
26 1 
180 
133 
70 
13 
363 
62 1 
20 
12 
11 
175 
212 
264 
115 
200 
8.6 51 
26.7 213 
25.7 119 
17.7 73 
13. I 26 
6.9 1 
1.3 1 
35.7 259 
61.1 193 
2.0 22 
1.2 10 
1.1 3 
17.9 40 
21.7 78 
27.0 150 
11.8 83 
20.5 120 
10.5 
44.0 
24.6 
15.1 
5.4 
0.2 
0.2 
53.5 
39.9 
4.5 
0.1 
0.6 
8.4 
16.5 
31.6 
17.5 
25.3 
pervious year (43.4% among males and 48.5% 
among females, p < 0.05). As regards the number 
of medicines, most of them had used either one 
(58.0%) or two (28.8%). Three or more drugs were 
used by 13.2%. 
Of drivers surveyed, 17.3% (259 out of 1500 
surveyed, Table 2) were using medicines chronic- 
ally (16.9% of males and 18.0% of females, 
p < 0.05), and, the older the individual the more 
Table 2-Patterns of medication use by Spanish drivers 
common this phenomenon was. Of these, 39% 
were using one drug, 39% two drugs, and 22% 
were using three or more drugs. Each of these 
individuals (n = 259, 5 1 1 drugs, Table 2) was using 
an average of 1.97 k 1.10 (mean SD) medicines 
(1.87k0.98 for males - n =  172, 323 drugs - 
and 2.16f 1.29 for females - n = 87, 188 drugs, 
p = 0.0506). 
The four most common chronically used groups 
of drugs (Table 3) were central nervous system 
drugs (21.7%), respiratory system drugs (19.2%), 
cardiovascular system drugs (14.9%) and drugs for 
the alimentary tract and metabolism (14.3%). 
Table 3 shows also the gender distribution regard- 
ing the medicines used. 
For 26.4% (Table 3) of the medication used 
chronically (135 out of 51 1) there was a warning in 
the Summary of Product Characteristics about the 
effect of the medication on the ability to drive and 
the safe use of machinery. Most medications 
supplied with this warning are cardiovascular 
system drugs (29.6%), central nervous system 
drugs (3 1.1 YO) and respiratory system drugs 
(22.2%). This data shows that 4.6% of drivers 
(26.4% of the drugs taken chronically by 17.3% of 
the population) were using medication that impairs 
driving performance. Table 3 also shows registered 
drugs in Spain, as well as those with a warning 
concerning the effect of the medication on driving 
ability (503 out of 3720: 13.5%). 
Among all those surveyed, 62.9% (943 out of 
1500) were current alcohol drinkers,') and 64.5% 
(167 out of 259) were among those who took 
medicines regularly. Only 21.6% of those using 
medicines (56 out of 259) admitted not having 
consumed alcohol when using medicines. It was 
Sample distribution Medication use in past year Chronic use of medication 
n n YO n YO 
Total 1500 676 45.1 259 17.3 
Sex 
Male 1016 
Female 484 
16-20 139 
21-30 484 
3 1-40 380 
41-50 253 
51-60 159 
61-70 71 
> 70 14 
Age range 
x 2  = 3.5 p < 0.05 x2 = 0.25 p < 0.05 
441 43.4 172 16.9 
235 48.5 87 18.0 
66 47.5 
235 48.5 
157 41.3 
105 41.5 
70 44.0 
38 53.5 
5 35.7 
28 20.1 
66 13.6 
50 13.2 
42 16.6 
40 25.2 
28 39.4 
5 35.7 
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not common for those surveyed (5.8%, n = 15; 
4.6%. n = 8 for males, and 8.O%, n = 7 for females, 
x 2  = 1.22, p < 0.05) to report that the medication 
used regularly affected their driving performance. 
Surveyed drivers who took drugs regularly were 
asked if they had been warned by health pro- 
fessionals about the effects of the medication used 
on driving skills: of these, 76.5% had never been 
warned, 19.4% had been warned on some 
occasions, and 4.1 YO had frequently been warned. 
Similar figures (x2 = 0.24, p < 0.05) were found 
between sexes (never: 75.6% males and 78.5% 
females; some occasions: 20.1% males and 17.7% 
females; frequently: 4.3% males and 3.8% females). 
DISCUSSION 
The present study shows a series of interesting data, 
the first of which is that medicines are frequently 
used by the population. Certain medications have 
been used by 45.1 YO during the last year and 17.3% 
use them chronically. It has to be pointed out that 
among regular users, the majority take an average 
of two medications. Another remarkable fact is the 
frequency of joint use of alcohol and medication. 
Finally, and what is more important, is that in 
three out of four cases concerning regular drug 
users, health professionals do not provide the 
patient with any information as regards the effect 
of the medication on driving ability. 
A comparison with the data obtained in other 
studies is difficult, due to a lack of standardization 
and the different types of methodology used. For 
instance, a study among the Austrian population 
revealed that drug intake was reported by 44% in 
the 3 months prior to the interview, and 27% in the 
previous week; furthermore, the average number of 
drugs used was 1 .84.5 In a French study on victims 
of road traffic accidents, 23.6% admitted having 
taken medication 5 days before the accident.6 In a 
Finnish study on casualties attending emergency 
departments, 31.6% said that they had used some 
medication a week earlier, whilst 15.3% admitted 
having used some medication a week prior to the 
a ~ c i d e n t . ~  In the United Kingdom, the frequency 
with which medicines are used among samples of 
the general driving population ranges from 5.5% 
to 22%; for those medications likely to have an 
effect on the central nervous system, the frequency 
is between 2% and 5%.8 
The present study also shows that these people 
often use various types of medication at the same 
time: 61% use two or more types of medication. 
This makes interactions more common and, conse- 
quently, causes a greater deterioration of psycho- 
motor performance in certain cases. What is not 
surprising, given the fact that alcohol is usually 
consumed in many European countries, is that 
alcohol consumption among the drivers surveyed is 
frequent: 62.9% among all those surveyed and 
64.5% among those who usually use medication; 
this confirms the previous f inding~. '~  A fact to be 
considered, is that consuming alcohol and using 
medication have negative effects on psychomotor 
performance, and, as a result, there is a greater 
accident risk. What is more, it is appropriate to 
mention that only a small number of those who 
normally use medication (5.8%) admit that that 
medication affects their driving performance. 
Within the European community, package 
inserts include a statement regarding the effects of 
medication on the ability to drive or use 
machinery." Furthermore, there has recently been 
accepted a three-tier warning system to identify the 
hazard potential of drugs on driving ability in the 
Summary of Product Characteristics." There is a 
statement concerning medication effects on the 
ability to drive among 26.4% of chronically used 
types of medication (4.6% for all surveyed). This is 
important, and it is logical to think that these 
individuals might experience impairment of certain 
of the faculties needed for safe driving. However, 
although the data do not permit us to state whether 
these people were in the habit of driving under the 
influence of medication, they do demonstrate the 
frequency with which medication that could impair 
driving performance is used. Furthermore, among 
all registered medications in Spain, 13.5% contain 
a warning regarding their effect on driving ability. 
Age and sex are among the major factors 
influencing the level of drug use:16 elderly and 
female are the most common characteristics of 
drug users. In the present study, chronic use of 
medication is more common among the aged 
population, while no significant differences were 
found between sexes (although the figures for 
women were higher than those for men). The 
reason could be related to the fact that most female 
drivers in Spain belong to the younger age groups. 
In 1993 there were about 15,882,000 drivers in 
Spain, men (67.3%) are more than twice as likely 
than females (32.7%) to be drivers. 
Finally, and more significantly, in 76.5% of 
cases, health professionals have never warned their 
patients about the effect of medication on driving 
0 1996 by John Wiley & Sons, Ltd. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOL. 5: 255-261 (1996) 
260 M. C.  DEL R10 AND F. J .  ALVAREZ 
performance. This finding coincides with the data 
encountered in previous studies.17 In spite of 
product information and  labelling, we believe'' 
that health professionals - doctors and chem- 
ists - should give advice to  their patients about 
the extent to which the medication prescribed (as 
well as illness and alcohol consumption) might 
interfere with their driving ability. 
The present study is not without several 
limitations (a low response rate, its descriptive 
nature, etc.), but it does highlight the large number 
of drivers using medication that could impair 
driving performance. Even so, we will admit that 
some possible variations in the gathered informa- 
tion could exist, because we cannot exclude over- 
or underreporting medication use. There is a need 
to standardize the methodology employed in this 
field,lg in order to characterize the extent of this 
phenomenon. In the last few years, not only have 
legislative rules been introduced, but special 
attention has been devoted to assessing the risk 
of being involved in a traffic accident while driving 
after using medication. Several s t ~ d i e s ' ~ - ~ '  have 
shown the increased risk of being involved in a 
road accident when driving under the influence of 
some medication, mainly psychotropic medication. 
The full impact of medication on driving is 
difficult to establish, but it is easy to accept that 
some kinds of medication interfere with driving 
performance and, therefore, could increase the risk 
of road accidents.' Road  accidents represent one of 
the main public health problems worldwide, and 
the need to develop policies geared towards their 
reduction is becoming more and more urgent. The 
role of medication as regards road safety should 
not be forgotten. Doctors should be aware of the 
possible influence of the medication prescribed on 
driving performance, and should inform their 
patients about it. 
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